HEPA

HEPION PHARMS INC by Hepion Pharmaceuticals, Inc. (HEPA)

About HEPION PHARMS INC by Hepion Pharmaceuticals, Inc. (HEPA)

Hepion Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development of drug therapy for treatment of chronic liver diseases. It focuses on the development of its product candidate, Rencofilstat, a cyclophilin inhibitor that targets biochemical pathways involved in the progression of liver disease. The company was founded on May 15, 2013 and is headquartered in Morristown, NJ.

Details

Daily high
$0.14
Daily low
$0.10
Price at open
$0.14
52 Week High
$0.22
52 Week Low
$0.03
Market cap
12.0M
Dividend yield
-
Volume
69,270
Avg. volume
39,416
P/E ratio
-.50

HEPION PHARMS INC by Hepion Pharmaceuticals, Inc. News

Details

Daily high
$0.14
Daily low
$0.10
Price at open
$0.14
52 Week High
$0.22
52 Week Low
$0.03
Market cap
12.0M
Dividend yield
-
Volume
69,270
Avg. volume
39,416
P/E ratio
-.50